For example, an analysis of nine studies, including 583 cases of pancreatic cancer, indicated that CD44 overexpression was predictive of poor five-year overall survival, more lymph node invasion, and a more-advanced stage, but was not associated with tumor size, differentiation, and distance metastasis [61]. Here, CD44 is linked to familial pancreatic carcinoma.